Iscaffpharma CEOPer Setterberg shares how they are focusing on developing better treatments of aggressive cancers by providing 3D scaffolds mimicking human tumour environment as a platform for research and development.
SLAS2026 International Conference & Exhibition
SLAS Europe 2026 Conference and Exhibition
